SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure after Q3 results highlighted weaker trading activity, with headline profit largely driven by gains on crypto holdings; the Binance hack and broader crypto weakness added to selling pressure. Traders are split between viewing the decline as a buying opportunity and worrying that soft volumes and shaken confidence in exchanges could prolong the downturn.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians quarterly results beat expectations and the company raised its full-year delivery outlook as the R2 ramp gained traction, driving bullish discussion about improving execution and future growth. Traders remain divided, with some expecting a recovery while others point to continued cash burn and a muted share-price reaction.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Bank of America upgrade, citing DraftKings Predictions exchange as a potential growth opportunity, has fueled rebound interest after a steep selloff. Traders remain divided over whether rising exchange activity can offset regulatory uncertainty, competition from Kalshi and Polymarket, and pressure on the sportsbook business.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its 80-event milestone, which starts database lock, unblinding and final analysis, is drawing attention ahead of the expected topline results. Bulls point to the trials long duration and extended GPS dosing as possible signs of durable survival benefit, while skeptics question the dosing changes and trial design; the share-price decline has added to the debate.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

Biotechs sector-wide swings and rotation are driving attention, with traders weighing weakness tied to rising-rate concerns and money moving between biotech and tech against hopes for renewed inflows and M&A. The debate is whether the pullback is a deeper correction or a buying opportunity, with XBIs support levels and upcoming biotech catalysts in focus.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Cornings quarterly earnings beat and upbeat outlook, driven by AI-related optical communications demand, are being weighed against a sharp share-price pullback and bearish chart signals. Traders are split between viewing the decline as an overreaction to strong results and pointing to put-heavy options activity and broken support as signs of further near-term pressure.

Select Sector SPDR Trust (The) - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

XLP is drawing attention as investors rotate toward defensive consumer staples amid weakness in technology and AI-related stocks, with traders highlighting the funds rebound toward record highs. The rally has prompted bullish technical commentary, while others caution that staples look stretched and the defensive trade may be crowded.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a 52-week high has focused attention on TGTX, with traders weighing BRIUMVIs sales momentum and Q3 results against anticipated subcutaneous BRIUMVI data. Buyout speculation and possible short covering are also prominent, but no acquisition is confirmed.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,715,255,345.65554501 with 589,238,256,711,817.89342663 in circulation. The last known price of Shiba Inu is 0.00000467 USD and is down -2.68 over the last 24 hours. It is currently trading on 1123 active market(s) with $35,462,996.64 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIB is drawing attention for choppy, largely range-bound trading, with repeated technical-chart posts describing consolidation and traders debating whether it can break resistance or resume falling. Long-term holders are buying dips and hoping for a meme-coin rally, while skeptics cite weak utility, token burns that have not shifted sentiment, and prolonged underperformance.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is under pressure amid a broader crypto and AI data-center selloff, with traders especially focused on its reliance on CoreWeave as Helioss tenant and the lack of a new tenant announcement. Some see the strong quarterly results, buyback authorization, and data-center growth as support, while others worry about customer concentration, financing risks, and management credibility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

High Tide Acquires Established Cannabis Store in Chestermere, Alberta

High Tide Acquires Established Cannabis Store in Chestermere, Alberta High Tide Acquires Established Cannabis Store in Chestermere, AlbertaPR NewswireCALGARY, AB, Oct. 9, 2026CALGARY, AB, Oct. 9, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE...

High Tide to Open First Canna Cabana in Peterborough, Ontario

High Tide to Open First Canna Cabana in Peterborough, Ontario High Tide to Open First Canna Cabana in Peterborough, OntarioPR NewswireCALGARY, AB, Oct. 1, 2026CALGARY, AB, Oct. 1, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the...

High Tide Named to Report on Business Ranking of Canada's Top Growing Companies for Sixth Consecutive Year

High Tide Named to Report on Business Ranking of Canada's Top Growing Companies for Sixth Consecutive Year High Tide Named to Report on Business Ranking of Canada's Top Growing Companies for Sixth Consecutive YearPR NewswireCALGARY, AB, Sept. 28, 2026 CALGARY, AB, Sept. 28, 2026 /PRNewswire...

Retailer Insights Report Shows Canna Cabana Widening Its Lead Among Canadian Cannabis Retailers

Retailer Insights Report Shows Canna Cabana Widening Its Lead Among Canadian Cannabis Retailers Retailer Insights Report Shows Canna Cabana Widening Its Lead Among Canadian Cannabis RetailersPR NewswireCALGARY, AB, Sept. 22, 2026 CALGARY, AB, Sept. 22, 2026 /PRNewswire/ -- /PRNewswire/ High Tide...

High Tide (HITI) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

High Tide Q3 2026 Earnings Call Transcript

High Tide (NASDAQ:HITI) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.
This transcript is brought to you by Benzinga APIs.read more...

High Tide Inc. Profit Climbs In Q3

(RTTNews) - High Tide Inc. (HITI) revealed earnings for its third quarter that Increased, from the same period last year...

High Tide Reports Record-Breaking Third Quarter 2026 Financial Results

High Tide Reports Record-Breaking Third Quarter 2026 Financial Results High Tide Reports Record-Breaking Third Quarter 2026 Financial ResultsPR NewswireCALGARY, AB, Sept. 14, 2026 RECORD Quarterly Revenue of $199 Million and Annualized Revenue Run Rate of Approximately $800 MillionRECORD Gross...

High Tide Continues Canadian Expansion with Three New Canna Cabana Locations

High Tide Continues Canadian Expansion with Three New Canna Cabana Locations High Tide Continues Canadian Expansion with Three New Canna Cabana Locations PR Newswire CALGARY, AB, Aug. 31, 2026 CALGARY, AB, Aug. 31, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI...

High Tide to Announce Third Fiscal Quarter 2026 Financial Results

High Tide to Announce Third Fiscal Quarter 2026 Financial Results High Tide to Announce Third Fiscal Quarter 2026 Financial Results PR Newswire CALGARY, AB, Aug. 25, 2026 CALGARY, AB, Aug. 25, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE...

High Tide, Inc. is a retail-focused cannabis company, which engages in the manufacturing and distribution of consumption accessories. It operates through the following segments: Bricks-and-Mortar, E-Commerce, and Medical Cannabis Distribution. The Bricks-and-Mortar segment refers to Canadian warehouse which supports the distribution of accessories. The E-Commerce segment includes U.S and international subsidiaries. The company was founded by Harkirat Grover in 2009 and is headquartered in Calgary, Canada.

High Tide Inc.

Tilray, Aurora Cannabis, Trulieve Pull Back After Trump Marijuana Order Rally Runs Out Of Steam

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Trump is seeking to move marijuana from a schedule 1 drug to a schedule 3 drug, from the levels of heroin, down to the levels of tylenol.&nbsp;</li><li>The executive order directs Trump’s administration to initiate the steps needed for the classification shift.</li></ul><p>Shares of Tilray Brands, Aurora Cannabis and Trulieve Cannabis pulled back on Thursday after an early rally sparked by U.S. President Donald Trump’s executive order to ease federal restrictions on marijuana lost momentum, as investors pared gains following the initial reaction to the policy move.</p><p>Shares of TLRY and ACB fell 5% and 3% respectively at the time of writing while TCNNF dropped 17%.&nbsp;</p><h2 class="st-heading-2">Trump Pushes Medical Marijuana</h2><p>President Donald Trump on Thursday signed an executive order to reschedule marijuana to make it less restrictive and available for “legitimate medical uses.”</p><p>Trump clarified that the order is not federal legalization and does not allow for recreational use nationwide but is instead aimed at improving medical marijuana and cannabidiol research. Trump is seeking to move marijuana from a schedule 1 drug to a schedule 3 drug, from the levels of heroin, down to the levels of tylenol.</p><p>“We have people begging for me to do this, people that are in great pain for decades,” Trump said while referring to patients suffering from extreme pain and incurable diseases including cancer. The executive order directs Trump’s administration to initiate the steps needed for the classification shift.</p><p>“Schedule III status will allow research studies to incorporate real-world evidence and models that can assess the health outcomes of medical marijuana and legal CBD products while focusing on long-term health effects in vulnerable populations like adolescents and young adults,” the White House said in a statement.</p><p>State regulations on cannabis are currently complex. While a few U.S. states currently permit the recreational use of cannabis, some allow it for medical purposes.</p><h2 class="st-heading-2">How Did Trump Decide?</h2><p>According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-18/trump-signs-order-to-reclassify-marijuana-in-industry-win">report</a> from Bloomberg, Trump came to the decision following discussions with Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz as well as cannabis-industry leaders including Trulieve Cannabis Corp CEO Kim Rivers. As per the report, the Centers for Medicare &amp; Medicaid Services is also expected to complete a plan to test making some Medicare patients eligible for therapies derived from cannabinoids.</p><p>Jazz Pharmaceuticals’ Epidiolex is currently the only drug approved by the U.S. Food and Drug Administration composed of CBD, a psychoactive compound found in cannabis.</p><h2 class="st-heading-2">Tilray Plans Expansion With Trump’s Push</h2><p>Tilray, a producer and distributor of medical and adult-use cannabis, subsequently confirmed plans to advance its U.S. medical cannabis operations with the formation of a unit called Tilray Medical USA, Inc. The unit aims to introduce medical-grade cannabis products in targeted therapeutic formats, the company said.</p><p>“This action [executive order] aligns regulation with a vast body of scientific and medical data supporting cannabis medical use and safety, economic progress, and a healthcare-focused framework, while creating a more credible foundation for medical cannabis research, clinical development, and regulatory clarity,” Tilray CEO Irwin D. Simon said.</p><h2 class="st-heading-2">Other Cannabis Firms Respond To Policy Change</h2><p>Cresco Labs applauded the executive order terming it a “cultural turning point” and a “historic shift.” Trulieve too applauded the decision while <a href="https://stocktwits.com/symbol/SMG">Scotts Miracle-Gro</a> expressed support highlighting that 39 states already legalize cannabis in some form. Scotts expects to combine its Hawthorne Gardening company subsidiary, which provides nutrients, lighting and other supplies to legal cannabis growing operations, with a cannabis company in 2026.</p><p><a href="https://stocktwits.com/symbol/HITI">High Tide</a> said that it is exploring structures that would allow it to expand its Canna Cabana retail brand into the U.S. through licensing.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> and <a href="https://stocktwits.com/symbol/CGC">CGC</a> trended in the ‘extremely bullish’ territory at the time of writing. Sentiment around <a href="https://stocktwits.com/symbol/MSOS">AdvisorShares Pure US Cannabis ETF</a> (MSOS), which tracks American operators, followed suit.</p><p>TLRY and CGC shares are down 8% and 39% this year, respectively.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/general-motors-eyes-ex-tesla-employee-sterling-anderson-as-potential-successor-to-ceo-mary-barra-report/cLegDrmRErL">General Motors Eyes Ex-Tesla Employee Sterling Anderson As Potential Successor To CEO Mary Barra: Report</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

Cannabis plants grow in the greenhouse at Vireo Health's medical marijuana cultivation facility, August 19, 2016 in Johnstown, New York. (Photo by Drew Angerer/Getty Images)

Trump clarified that the order is not federal legalization and does not allow for recreational use nationwide but is instead aimed at improving medical marijuana and cannabidiol research.

Trump clarified that the order is not federal legalization and does not allow for recreational use nationwide, but is instead aimed at improving medical marijuana and cannabidiol research.


Canopy Growth Corp

High Tide Inc

AdvisorShares Pure US Cannabis ETF

Scotts Miracle-Gro Company

Tilray Brands Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.01	--	--	N/A
Q3 '26	$0.01	$0.09	641.34%	BEAT
Q2 '26	-$0.02	$0.01	141.10%	BEAT
Q1 '26	-$0.00	$0.01	399.79%	BEAT
Q4 '25	$0.01	-$0.48	-8333.16%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

HITI Earnings

Upcoming Earnings: Q4 '26

Historical Earnings